Literature DB >> 12406934

Disclosure at Pfizer Canada.

Joel Lexchin1.   

Abstract

Year:  2002        PMID： 12406934      PMCID： PMC128388     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Inaccessibility of drug reports.

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2002-05-14       Impact factor: 8.262

2.  Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.

Authors:  C R Conti; C J Pepine; M Sweeney
Journal:  Am J Cardiol       Date:  1999-03-04       Impact factor: 2.778

3.  Sildenafil, a novel effective oral therapy for male erectile dysfunction.

Authors:  M Boolell; S Gepi-Attee; J C Gingell; M J Allen
Journal:  Br J Urol       Date:  1996-08

4.  Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.

Authors:  A Morales; C Gingell; M Collins; P A Wicker; I H Osterloh
Journal:  Int J Impot Res       Date:  1998-06       Impact factor: 2.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.